145 related articles for article (PubMed ID: 34383091)
21. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
22. The prognostic impact of the lymphocyte-to-C-reactive protein ratio in patients with unresectable or recurrent advanced gastric cancer treated with first- and second-line treatment.
Matsunaga T; Saito H; Fukumoto Y; Kuroda H; Taniguchi K; Takahashi S; Osaki T; Iwamoto A; Fukuda K; Shimizu S; Shishido Y; Miyatani K; Fujiwara Y
Surg Today; 2023 Aug; 53(8):940-948. PubMed ID: 36595075
[TBL] [Abstract][Full Text] [Related]
23. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
[TBL] [Abstract][Full Text] [Related]
24. Association of systemic inflammation and low performance status with reduced survival outcome in older adults with cancer.
Ruan GT; Xie HL; Zhang HY; Zhang Q; Deng L; Wang ZW; Zhang X; Ge YZ; Hu CL; Tang M; Song MM; Zhang XW; Liu T; Li XR; Zhang KP; Yang M; Gong YZ; Chen YB; Yu KY; Cong MH; Pan L; Tang WZ; Wang KH; Shi HP
Clin Nutr; 2022 Oct; 41(10):2284-2294. PubMed ID: 36096062
[TBL] [Abstract][Full Text] [Related]
25. A Novel Systemic Inflammatory Score Combined With Immunoinflammatory Markers Accurately Reflects Prognosis in Patients With Esophageal Cancer.
Suzuki T; Ishibashi Y; Tsujimoto H; Nomura S; Kouzu K; Itazaki Y; Sugihara T; Harada M; Ito N; Sugasawa H; Kishi Y; Ueno H
In Vivo; 2020; 34(6):3705-3711. PubMed ID: 33144487
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Significance of Preoperative Lymphocyte-to-C-Reactive Protein Ratio in Patients with Non-Metastatic Colorectal Cancer.
Ou W; Zhou C; Zhu X; Lin L; Xu Q
Onco Targets Ther; 2021; 14():337-346. PubMed ID: 33469310
[TBL] [Abstract][Full Text] [Related]
27. Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma.
Tian R; Yan H; Zhang F; Sun P; Wu AR; Zhang M; Jiang YL; Wu J; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Sep; 7(38):61533-61543. PubMed ID: 27517497
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer.
Zhang HY; Xie HL; Ruan GT; Zhang Q; Ge YZ; Liu XY; Tang M; Song MM; Lin SQ; Yang M; Zhang XW; Xu HX; Song CH; Shi HP
BMC Cancer; 2022 Oct; 22(1):1080. PubMed ID: 36266627
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of number of lymph node metastasis on survival in patients with pathological T3 esophageal carcinoma.
Gulben K; Irkin F; Yazı M; BerberoGlu U
Neoplasma; 2017; 64(1):131-135. PubMed ID: 27881014
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
31. [Establishment of a nomogram model for predicting lymph node metastasis in patients with cN0 gastric cancer based on combination of preoperative C-reactive protein/albumin ratio].
Liu Q; Peng J; Jiang HG; Wang WB; Dai J; Zhou FX
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):599-603. PubMed ID: 31434451
[No Abstract] [Full Text] [Related]
32. Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer.
Iseda N; Iguchi T; Hirose K; Itoh S; Honboh T; Sadanaga N; Matsuura H
Am Surg; 2023 Nov; 89(11):4452-4458. PubMed ID: 35920820
[TBL] [Abstract][Full Text] [Related]
33. The Association of the Lymphocyte-to-C-Reactive-Protein Ratio With Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Nakazano M; Nagasawa S; Hara K; Komori K; Tamagawa H; Maezawa Y; Segami K; Kano K; Ogata T; Yukawa N; Rino Y; Oshima T
In Vivo; 2022; 36(1):482-489. PubMed ID: 34972752
[TBL] [Abstract][Full Text] [Related]
34. Rad51 and Systemic Inflammatory Indicators as Novel Prognostic Markers in Esophageal Squamous Cell Carcinoma.
Wu N; Song Y; Zhu Y; Pang L; Chen Z; Chen X
Technol Cancer Res Treat; 2024; 23():15330338231216333. PubMed ID: 38258400
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte-to-C reactive protein ratio as novel inflammatory marker for predicting outcomes in hemodialysis patients: A multicenter observational study.
Chen X; Guo W; Diao Z; Huang H; Liu W
Front Immunol; 2023; 14():1101222. PubMed ID: 36936907
[TBL] [Abstract][Full Text] [Related]
36. Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer.
Ibuki Y; Hamai Y; Hihara J; Emi M; Taomoto J; Furukawa T; Yamakita I; Kurokawa T; Okada M
World J Surg; 2017 Jun; 41(6):1558-1565. PubMed ID: 28120093
[TBL] [Abstract][Full Text] [Related]
37. Prognostic role of preoperative lymphocyte/C-reactive protein associated with upper gastrointestinal cancer: a meta-analysis.
Ye Y; Wu G; Yuan H; Zheng Y; Wang Y; Guo Q
Front Oncol; 2023; 13():1181649. PubMed ID: 37849797
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
[TBL] [Abstract][Full Text] [Related]
39. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
40. Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study.
Wang L; Zhang YL; Jiang C; Duan FF; Yuan ZY; Huang JJ; Bi XW
J Inflamm Res; 2022; 15():3957-3974. PubMed ID: 35860229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
